Related Experiment Video
Updated: Apr 7, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association between Ophthalmological Changes and Cardiovascular Diseases in Patients with Chronic Kidney Disease
Hirohiko Nokiba1, Takashi Takei, Chikako Suto
1Department of Medicine, Kidney Center, Tokyo Women's Medical University.
Insights
Retinal arterial sclerosis, assessed by the Scheie S grade, is linked to arterial stiffness and cardiovascular disease (CVD) history in hemodialysis patients. This retinopathy classification may help predict CVD risk in chronic kidney disease patients.
Area of Science:
- Ophthalmology
- Nephrology
- Cardiology
Background:
- Patients with chronic kidney disease (CKD) undergoing hemodialysis (HD) have a high prevalence of cardiovascular diseases (CVD).
- Arterial sclerosis is a key factor in CVD development.
- The association between retinal arterial sclerosis and CVD in CKD patients on HD remains understudied.
Purpose of the Study:
- To assess retinal arterial sclerosis in patients with CKD on HD.
- To investigate the relationship between retinal arterial changes and arterial stiffness.
- To explore the link between retinal arterial changes and a past history of CVD.
Main Methods:
- Data from 44 CKD patients on HD were analyzed.
- Ophthalmological findings, including Scheie classification of retinopathy, were evaluated.
- Arterial stiffness (pulse wave velocity) and past CVD history were assessed; medications and biochemical parameters were recorded.
Main Results:
- A significant correlation was observed between arteriosclerotic retinopathy (Scheie S grade) and arterial stiffness (p=0.001).
- The presence of arteriosclerotic retinopathy was also significantly associated with a past history of CVD (p=0.045).
- No other ophthalmological findings correlated with arterial stiffness or CVD history.
Conclusions:
- Retinopathy classification, specifically the Scheie S grade, may serve as a useful indicator for predicting arterial stiffness.
- Ophthalmoscopic examination of retinopathy can help identify patients at higher risk for arterial stiffness and associated CVD.
- This study highlights a potential non-invasive method for risk stratification in CKD patients on HD.
Aims:
Patients with chronic kidney disease (CKD) undergoing hemodialysis (HD) have a high prevalence of cardiovascular diseases (CVD). Arterial sclerosis plays an important role in the pathogenesis of CVD. However, to date, there have been no reports of assessment of the association between retinal arterial sclerosis and CVD in patients with CKD on HD. The aim of this study was to assess retinal arterial sclerosis and to investigate the relationship between retinal arterial changes in patients with CKD on HD and arterial stiffness/past history of CVD.
Methods:
We examined the data of 44 patients (21 female, 23 male) with CKD receiving HD treatment at Saiseikai Kurihashi Hospital. The relationship between ophthalmological changes and arterial stiffness [pulse wave velocity (PWV)] or past history of CVD was evaluated. All medications being taken were recorded, and biochemical parameters were analyzed.
Results:
Significant correlations were found between the presence of arteriosclerotic retinopathy [Scheie classification S grade (grade 0: 7 patients, grade 1: 18 patients, grade 2: 14 patients, grade 3: 4 patients, and grade 4: 1 patient)] and results of the evaluation of arterial stiffness (PWV) and past history of CVD (p=0.001, p=0.045). Other ophthalmological findings were not associated with a history of CVD or arterial stiffness.
Conclusion:
We showed that the classification (Scheie S grade) of retinopathy on ophthalmoscopic examination may be a useful tool for predicting arterial stiffness and its association with CVD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Hypertension III: Clinical Manifestations and Diagnostic Studies

